Acquisition by Bishop Hans Edgar of 14285 shares of Sana Biotechnology subject to Rule 16b-3

SANA Stock  USD 4.30  2.65  160.61%   
About 55% of Sana Biotechnology's investors are presently thinking to get in. The analysis of the overall investor sentiment regarding Sana Biotechnology suggests that some traders are interested. The current market sentiment, together with Sana Biotechnology's historical and current headlines, can help investors time the market. In addition, many technical investors use Sana Biotechnology stock news signals to limit their universe of possible portfolio assets.
  
Filed transaction by Sana Biotechnology Director. Grant, award or other acquisition pursuant to Rule 16b-3(d)

Read at macroaxis.com
Sana insider trading alert for acquisition of common stock by Bishop Hans Edgar, Director, on 6th of January 2025. This event was filed by Sana Biotechnology with SEC on 2025-01-06. Statement of changes in beneficial ownership - SEC Form 4

Sana Biotechnology Fundamental Analysis

We analyze Sana Biotechnology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sana Biotechnology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sana Biotechnology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Debt To Equity

Debt To Equity Comparative Analysis

Sana Biotechnology is currently under evaluation in debt to equity category among its peers. Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.

Sana Biotechnology Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sana Biotechnology stock to make a market-neutral strategy. Peer analysis of Sana Biotechnology could also be used in its relative valuation, which is a method of valuing Sana Biotechnology by comparing valuation metrics with similar companies.

Peers

Sana Biotechnology Related Equities

OLMAOlema Pharmaceuticals   9.73   
0%
77.0%
RVMDRevolution Medicines   0.20   
0%
1.0%
KYMRKymera Therapeutics   0.98   
7.0%
0%
NKTXNkarta   1.24   
9.0%
0%
LYELLyell Immunopharma   1.52   
12.0%
0%
HOOKHookipa Pharma   1.59   
12.0%
0%
DAWNDay One   1.61   
12.0%
0%
AMLXAmylyx Pharmaceuticals   1.82   
14.0%
0%
CGEMCullinan Oncology   3.72   
29.0%
0%
BPMCBlueprint Medicines   3.96   
31.0%
0%
APLSApellis Pharmaceuticals   4.71   
37.0%
0%
TERNTerns Pharmaceuticals   6.75   
54.0%
0%
ZNTLZentalis Pharmaceuticals   7.02   
56.0%
0%
GLUEMonte Rosa   8.27   
66.0%
0%
XFORX4 Pharmaceuticals   8.57   
68.0%
0%
GBIOGeneration Bio   12.50   
100.0%
0%

Complementary Tools for Sana Stock analysis

When running Sana Biotechnology's price analysis, check to measure Sana Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sana Biotechnology is operating at the current time. Most of Sana Biotechnology's value examination focuses on studying past and present price action to predict the probability of Sana Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sana Biotechnology's price. Additionally, you may evaluate how the addition of Sana Biotechnology to your portfolios can decrease your overall portfolio volatility.
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
CEOs Directory
Screen CEOs from public companies around the world
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA